The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $195.45

Today's change-2.66 -1.34%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.
 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $195.45

Today's change-2.66 -1.34%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.

Illumina Inc down (U.S.)$2.66

Illumina Inc closed lower Thursday, dropping (U.S.)$2.66 or 1.34% to (U.S.)$195.45. Shares have lost 3.21% over the last five days, but have gained 5.89% over the last year to date. This security has outperformed the S&P 500 by 12.42% during the last year.

Key company metrics

  • Open(U.S.) $199.11
  • Previous close(U.S.) $198.11
  • High(U.S.) $200.00
  • Low(U.S.) $194.63
  • Bid / Ask(U.S.) $189.52 / (U.S.) $200.19
  • YTD % change+5.89%
  • Volume1,112,598
  • Average volume (10-day)1,611,978
  • Average volume (1-month)1,393,990
  • Average volume (3-month)1,465,548
  • 52-week range(U.S.) $145.12 to (U.S.) $242.37
  • Beta0.97
  • Trailing P/E59.76×
  • P/E 1 year forward57.23×
  • Forward PEG2.72×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.27
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+23.45%

Based on its net profit margin of 23.45%, Illumina Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.38%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 28, 201506/28/2015Mar 29, 201503/29/2015Dec 28, 201412/28/2014Sep 28, 201409/28/2014
Revenue539539512481
Total other revenue--------
Total revenue539539512481
Gross profit376375385334
Total cost of revenue163164127147
Total operating expense387362309361
Selling / general / administrative124116122120
Research & development969214385
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)4-9-8310
Other operating expenses, total----00
Operating income152176203119
Interest income (expense), net non-operating-11-11-11-11
Gain (loss) on sale of assets--------
Other--------
Income before tax141178192112
Income after tax10213715393
Income tax, total39413919
Net income10213715393
Total adjustments to net income--------
Net income before extra. items10213715393
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items10213715393
Inc. avail. to common incl. extra. items10213715393
Diluted net income10213715393
Dilution adjustment--------
Diluted weighted average shares149149149148
Diluted EPS excluding extraordinary itemsvalue per share0.690.921.030.63
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.700.870.590.69